Azacitidine Injection Shortage
Last Updated: May 18, 2023
Status: Current
Products Affected - Description
-
- Azacitidine lyophilized powder for injection, Cipla USA, 100 mg, vial, 1 count, NDC 69097-0805-40
- Azacitidine lyophilized powder for injection, Mylan Institutional (Viatris), 100 mg, vial, 1 count, NDC 67457-0254-30 - discontinued
- Azacitidine lyophilized powder for injection, Wockhardt USA, 100 mg, vial, 1 count, NDC 64679-0096-01 - discontinued
Reason for the Shortage
-
- Accord had azacitidine on back order due to a shortage of the raw ingredient.
- Armas has azacitidine injection available.
- Cipla does not expect more supply in the near future.
- Celgene (now part of Bristol-Myers Squibb) had Vidaza on shortage due to increased demand.
- Dr. Reddy's has azacitidine injection available.
- Fresenius Kabi has azacitidine injection available.
- Hikma has azacitidine injection available.
- Meitheal has azacitidine injection available.
- Sandoz has azacitidine injection available.
- Viatris discontinued azacitidine in September 2022.
- Wockhardt discontinued azacitidine in mid-2022.
Available Products
-
- Vidaza lyophilized powder for injection, Bristol-Myers Squibb, 100 mg, vial, 1 count, NDC 59572-0102-01
- Azacitidine lyophilized powder for injection, Accord, 100 mg, vial, 1 count, NDC 16729-0306-10
- Azacitidine lyophilized powder for injection, Armas Pharmaceuticals, 100 mg, vial, 1 count, NDC 72485-0201-01
- Azacitidine lyophilized powder for injection, Dr. Reddy's, 100 mg, vial, 1 count, NDC 43598-0305-62
- Azacitidine lyophilized powder for injection, Dr. Reddy's, 100 mg, vial, 1 count, NDC 43598-0143-62
- Azacitidine lyophilized powder for injection, Eugia US, 100 mg, vial, 1 count, NDC 55150-0393-01
- Azacitidine lyophilized powder for injection, Fresenius Kabi, 100 mg, vial, 1 count, NDC 63323-0771-39
- Azacitidine lyophilized powder for injection, Hikma, 100 mg, vial, 1 count, NDC 00143-9606-01
- Azacitidine lyophilized powder for injection, Meitheal Pharmaceuticals, 100 mg, vial, 1 count, NDC 71288-0115-30
- Azacitidine lyophilized powder for injection, Sandoz, 100 mg, vial, 1 count, NDC 00781-3253-94
Estimated Resupply Dates
-
- Most marketed presentations are available.
Updated
Updated May 18, 2023 by Michelle Wheeler, PharmD, Drug Information Specialist. Created November 2, 2020 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2023, Drug Information Service, University of Utah, Salt Lake City, UT.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.